Press Releases
Aug 6, 2026
Press release
Corporate and finance
Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights
Jul 30, 2026
Corporate and finance
Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026
Jun 1, 2026
Corporate and finance
Novavax to Participate in 2026 Jefferies Global Healthcare Conference
May 7, 2026
Press release
Corporate and finance
Novavax to Participate in BofA Securities 2026 Health Care Conference
May 6, 2026
Corporate and finance
Novavax Reports First Quarter 2026 Financial Results and Operational Highlights
Apr 29, 2026
Press release
Corporate and finance
Novavax to Report First Quarter 2026 Financial Results on May 6, 2026
Apr 18, 2026
Statement
COVID-19,Corporate and finance,Partnerships
Nuvaxovid™ COVID-19 Vaccine Showed Better Tolerability than mNEXSPIKE in Head-to-head Sanofi-led Phase 4 Study
Mar 30, 2026
Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development
Feb 26, 2026
Corporate and finance
Novavax to Participate in Upcoming Investor Conferences
Feb 26, 2026
Corporate and finance
Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Showper page